JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2023-09-25 ms1000001256929453 来自甘肃省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：给药综述
经验分享：23年2月投稿
大约1周后送审
6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间
8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到
10天左右接收
总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。

28 0

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2022-12-28 ms7000000127014533

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：缓释;药物
经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-01-04 12436392m12(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0
偏重的研究方向：药物;缓释
经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。

92 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-03-31 147e0ba8m25(暂无昵称)

审稿速度:6.0 | 投稿命中率:75.0
经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收

79 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2022-07-24 研途无量

审稿速度:6.0
经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2019-06-21 ms8780191241558819

2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

关键词最少几个？

61 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-27 衣谷

一般期刊要求关键词有多少个？

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159566, encodeId=2dfe2159566f0, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：给药综述 经验分享：23年2月投稿 大约1周后送审 6月份返回一审意见，审稿人1小修意见4条，审稿人2 ，大修意见16条，小修意见5条，2个月修改时间 8月份投递修改稿，审稿人1同意，审稿人2意见没有追踪到 10天左右接收 总体来说稿件质量要求高，审稿比较慢，4个月的等待太漫长了。但结果是好的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3be98380656, createdName=ms1000001256929453, createdTime=Mon Sep 25 10:44:28 CST 2023, time=2023-09-25, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2107967, encodeId=83ba210e967e7, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：缓释;药物 经验分享：2022.6.1投稿 2022.7.1under review 2022.9.1 有审稿意见:两个审稿人，每人分别10个意见，不是很难回答，要求补充实验。 2022.10.25修回 2022.11.6号审稿人再次要求补充实验 2022.11.26修回再次送审后 2022.12.28接收总体来说还是挺慢的，请大家慎重考虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fe98122594, createdName=ms7000000127014533, createdTime=Wed Dec 28 23:48:07 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913548, encodeId=1ba69135483c, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:3000.0 偏重的研究方向：药物;缓释 经验分享：2个审稿专家，审稿周期近两月，审稿意见共10余条，大多都不难回复。修改回去要求润色语言，第二天接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Mon Jan 04 11:45:42 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952891, encodeId=a6b895289187, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2020年10月15日投稿，2021年2月12日小修（两个审稿人，问题大概10个，比较简单），3月11日修回，再次外审后3月31日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61385251391, createdName=147e0ba8m25(暂无昵称), createdTime=Wed Mar 31 19:17:31 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234442, encodeId=b72f123444279, content=审稿速度:6.0 经验分享：审稿速度太慢，太浪费时间，审稿5个月却拒稿了，太坑人了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36042049395, createdName=研途无量, createdTime=Sun Jul 24 17:16:38 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852128, encodeId=68d08521281e, content=2个审稿人，审稿很快，2-3个周就有审稿意见，一次大修一次小修，（我补的时间长），小修后第二天就接受了，编辑很负责，很好得杂志。希望稳定增长。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bff55414034, createdName=ms8780191241558819, createdTime=Fri Jun 21 21:41:34 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100375, encodeId=a62611003e5d2, content=关键词最少几个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100376, encodeId=537711003e600, content=一般期刊要求关键词有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541967, encodeId=375c54196ece, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-14 zhengxiaobing

跨过一分大关,神仙保佑!!明年超过2分吧

270 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务